News

STUART, FL – November 18, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.

STUART, FL – September 21, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced that a total of 50 care box donations have now been shipped to underserved, underfunded community medical centers and clinics in association with iRemedy’s Project Restart program launched in early August 2020.

STUART, FL – August 24, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced that over the past week, the Company has shipped Project Restart ‘care boxes’ to 15 more community care organizations providing care to patients in underserved, underprivileged communities and neighborhoods in the U.S.; bringing the total to over 21 shipments since the program’s launch on August 5, 2020.

STUART, FL – August 13, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, announced that the launch of Project Restart earlier this month has been received with great enthusiasm and is already having positive impact on community care providers across the country.

STUART, FL – August 5, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced the formation of Project Restart, an initiative to help address the severe shortage of medical supplies in demand by local, underfunded community health centers and clinics.

The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, and Verséa Holdings, a U.S.-based healthcare company focused on clinical research and novel scientific discoveries and products, today jointly announced the commercial availability of a COVID-19 Rapid Test Serology Kit that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for administration by U.S. healthcare providers in testing patients for coronavirus infection.

Coalition’s Aim Will Be to Fully Align the Security, Economic, Social and Geopolitical Interests of Key Stakeholders in the U.S. Healthcare Supply Chain through the Manufacture and Distribution of Medical Devices/Equipment, Supplies and Drugs Made in America

Innovative medical supply solution avoids supply chain shortfalls and begins delivery of millions of units of verified, critically-needed PPE as COVID-19 case count rises

Road Patrol Zachary Pecci and Corporal Daniel Duran Accept Protective Masks Donation from iRemedy team for Stuart Police Department. Left to Right: Road Patrol Zachary Pecci, Amanda Somsy, Marcus Allen, CorporateDaniel Duran, Keisha Graham, Tony Paquin. NEW YORK, NY – April 23...

orms Strategic Partnership with Global Procurement Powerhouse; Successfully Fulfilling and Guaranteeing Needed Medical Supply for U.S. Health Systems, Tribal Nations and Government Agencies NEW YORK, NY – April 21, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), parent of iRemedySupply.com...